Northerner
Admin (Retired)
- Relationship to Diabetes
- Type 1
The aim of this survey was to establish the limitations of open loop continuous subcutaneous insulin infusion (CSII) as perceived by current users of the technology, and to ascertain their interest in and requirements for a non-electronic implantable closed loop insulin pump, INSmart, currently under development for the treatment of type 1 diabetes. INSmart has been surgically implanted in the peritoneum in animal models and continuously restored normoglycaemia.
A bottom-up survey design was used to determine both positive and negative experiences of patients currently using CSII to define the performance characteristics they would require from a non-electronic, implantable closed loop insulin pump.
http://onlinelibrary.wiley.com/doi/10.1002/pdi.1822/full
A bottom-up survey design was used to determine both positive and negative experiences of patients currently using CSII to define the performance characteristics they would require from a non-electronic, implantable closed loop insulin pump.
http://onlinelibrary.wiley.com/doi/10.1002/pdi.1822/full